PharmStockPharmacy Stock

Vigamox Ophthalmic Solution
Vigamox Ophthalmic Solution

55.67
Used to address eye conditions, this generic medicine prevents bacterial proliferation on the surface of the eye to resolve inflammation.
Ingredient
Moxifloxacin
Category
Eye Care
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Moxifloxacin
Reference Brand
Moxifloxacin
Product Origin
Generic Brand
Product Manufacturer
Alcon
Product Form
Ophthalmic Solution
Regulatory Classification
Prescription Only Medicine
Primary Category
Antibiotics
Product Category
Fluoroquinolone
Pharmacological Class
Ophthalmic Antibacterial
Clinical Indications
Bacterial conjunctivitis
Manufacturer Description
Utilized to manage superficial ocular bacterial pathogens to support eye tissue health and target bacterial replication.
Mechanism of Action
Blocks DNA gyrase and topoisomerase IV enzymes, preventing microbial transcription, repair, and cell division.
Route of Administration
Ophthalmic
Onset Time
24 hours
Duration
8 hours
Contraindications
Hypersensitivity to moxifloxacin or other fluoroquinolones
Severe Adverse Events
Severe corneal ulceration — requires immediate medical attention
Common Side Effects
Local eye discomfort, Temporary blurred vision
Uncommon Side Effects
Conjunctival redness, Dry eyes, Subconjunctival hemorrhage
Pregnancy Safety Warnings
TGA Category C: Minimal systemic absorption. Safe. Breastfeeding: Compatible.
Age Restrictions
Approved for infants over one year, children, and adults.
Storage Guidelines
Store below 25°C. Do not freeze.
Information related to Vigamox Ophthalmic Solution is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access OCP Medication Online - Cyproterone Ethinylestradiol Anti-Androgen OCP